TrialJournal of neurotrauma2019

Copenhagen Head Injury Ciclosporin Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury Patients.

Jesper Kelsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.